Atlas Trials

Risk of Urinary Retention With Retigabine

Clinical trial NCT01462656 · TERMINATED

Trial details

NCT number
NCT01462656
Sponsor
GlaxoSmithKline
Status
TERMINATED
Study type
OBSERVATIONAL
Epilepsy
Start date
2011-02-01
Primary completion
2016-08-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.